F. Hoffmann-La Roche AG
Explore F. Hoffmann-La Roche
Core profile pages, annual revenue records, and related research hubs for this company.
F. Hoffmann-La Roche AG
Explore F. Hoffmann-La Roche
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$77.19B
Market Cap
$327.5B
Employees
112,774
Roche reported CHF 61.5 billion in 2025 group sales. Pharmaceuticals sales were CHF 47.7 billion and Diagnostics sales were CHF 13.8 billion. Core operating profit was CHF 21.8 billion, and R&D core investments were CHF 12.2 billion. For USD comparability, this profile converts CHF 61.5 billion at 1 CHF = 1.25506 USD.
Revenue Trend Analysis
YoY Change
+1.6%
2-Year CAGR
+0.8%
Peak Year
2025
Trend
Consistent Growth
F. Hoffmann-La Roche AG has reported revenue across 3 fiscal years, compounding at +0.8% annually over 2 years. The most recent year saw a 1.6% increase versus the prior year. Revenue peaked in 2025 at $77.2B. Out of 2 reported periods, 2 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | YoY Change |
|---|---|---|
| FY2025 | $77.2B | +1.6% |
| FY2024 | $75.9B | +0.1% |
| FY2023 | $75.9B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "F. Hoffmann-La Roche AG Revenue & Financials." CorpDigest, https://corpdigest.com/company/roche/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>F. Hoffmann-La Roche AG reported $77B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/roche/financials" target="_blank" rel="noopener">CorpDigest — F. Hoffmann-La Roche AG financials</a></div>